The American Society of Gene & Cell Therapy
The American Society of Gene + Cell Therapy (ASGCT) is a public charity based in Waukesha, Wisconsin, and a professional organization advancing cell and gene therapies. It supports research and career development in the field through awards and grants, alongside educational, publishing, and advocacy programs.
The American Society of Gene & Cell Therapy at a glance
In short: The American Society of Gene & Cell Therapy gave $1.0M across 10 grants in 2024 (avg $104K), top state Georgia. 40% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $1,040,000
- -30.2% vs 2023
- Grants made (2024)
- 10
- -33.3% vs 2023
- Average grant
- $104,000
- +4.7% vs 2023
- Median grant
- $100,000
- Total assets
- $27,046,811
- +13.6% vs 2023
- New grantees (estimate)
- 40% first-time grantees (4 of 10, 2024; small sample)
- Primary geography
- Georgia (19% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to The American Society of Gene & Cell Therapy
- How to Apply
-
Application requirements described for the Career Development Awards include selecting a research topic and providing a mentor letter of support.
- Contact
Mailing address: 20800 Swenson Dr 300, Waukesha, WI 53186
Phone: (414) 278-1341
Website: https://asgct.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who The American Society of Gene & Cell Therapy funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was University of North Carolina at Chapel Hill ($200K). Together the top 10 received $1.0M.
Grant Size Distribution
49 grants across all recorded years
The most common grant size was in the $100–250K range: 37 grants of 49 (76%).
Geographic Focus
Where this funder awards grants
The 2024 filing reports grant dollars distributed to recipients in Georgia (19%), Pennsylvania (19%), Washington (19%), Missouri (10%), and Alabama (10%). Other listed 2024 grant recipients were in California, Michigan, and Maryland. These locations reflect the reported grants and do not establish a broader geographic focus.
Grant Distribution by State
Share of 2024 grant dollars across all 10 itemized grants.
States
Cities
Is The American Society of Gene & Cell Therapy open to new grantees?
40%
first-time grantees, 2024
In 2024, 4 of 10 grantees (40%) were first-time recipients. With only 10 grantees, that is a small sample: one grantee more or less moves the share by about 10 points. First grants averaged $100K; repeat grants $107K. How we count
Medians: $100K first-time, $100K repeat.
- 30% of 2024 grantees were also funded in 2023. Method
- Giving held roughly steady from 2021 to 2024 (−10%). Method
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $300K (2020) to $1.5M (2023). In 2024 it made 10 grants totaling $1.0M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| University of North Carolina at Chapel Hill Atlanta, GA | Career Development | $200,000 |
| Trustees of the University PA Philadelphia, PA | Career Development | $200,000 |
| Washington University St. Louis, MO | Career Development | $100,000 |
| Fred Hutchinson Cancer Research Center Seattle, WA | Career Development | $100,000 |
| Auburn University Auburn University, AL | Career Development | $100,000 |
| The Regents of the University of California San Francisco San Francisco, CA | Career Development | $100,000 |
| Regents of the University of Michigan Ann Arbor, MI | Career Development | $100,000 |
| HDT Bio Corp Seattle, WA | Career Development | $100,000 |
| Foundation for the NIH North Bethesda, MD | Amp Bespoke Gene Therapy Consortium | $25,000 |
| National Institutes of Health (NIH) Bethesda, MD | Ncats Grant | $15,000 |
Ready to take the next step with The American Society of Gene & Cell Therapy?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $27,046,811 | $16,914,337 | $14,579,126 | $1,040,000 | 10 | $1,024,374 |
| 2023 | $23,810,378 | $16,370,708 | $13,754,627 | $1,490,000 | 15 | $643,264 |
| 2022 | $20,486,557 | $12,483,052 | $10,958,628 | $800,000 | 7 | $121,557 |
| 2021 | $15,452,389 | $8,934,604 | $6,172,037 | $1,150,000 | 11 | $119,787 |
| 2020 | $11,546,982 | $6,516,210 | $4,511,431 | $300,000 | 6 | $84,023 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. Its stated programs include an annual meeting, Molecular Therapy journals, advocacy, workshops, a policy summit, career development, patient education, and other educational activities.
Its Career Development Awards support independent pilot studies in cell and gene therapy. Topics include viral vector development, gene targeting and correction, oligonucleotide therapeutics, cell therapies, immunological aspects of gene therapy and vaccines, and methods for delivering gene therapeutics. The program describes its intended applicants as early-career scientists and postdoctoral fellows.
The 2024 filing lists grants to universities, research and medical organizations, and government-related entities. For example, the University of Pennsylvania describes its mission as providing education, pioneering research, and patient care. Fred Hutchinson Cancer Research Center describes its work as research spanning foundational biology to population-level health, with a focus on cancer and related diseases. The Foundation for the National Institutes of Health describes its mission as creating public-private partnerships to advance biomedical discoveries and improve people’s lives.
Grantmaking
In 2024, ASGCT reported 10 grants totaling $1,040,000. Grant amounts ranged from $15,000 to $200,000, with a median of $100,000. The largest awards included $200,000 each to the University of North Carolina at Chapel Hill and the Trustees of the University of Pennsylvania, both for career development. Other $100,000 career-development grants went to Washington University, Fred Hutchinson Cancer Research Center, Auburn University, the Regents of the University of California San Francisco, the Regents of the University of Michigan, and HDT Bio Corp. The filing also lists $25,000 to the Foundation for the NIH for the AMP Bespoke Gene Therapy Consortium and $15,000 to the National Institutes of Health for an NCATS grant.
ASGCT’s website describes Career Development Awards of $100,000 each, with up to six awards across listed research topics. Applicants must be ASGCT members in good standing or have a membership application pending; a mentor letter of support is required. Citizenship is not required, but both the applicant and mentor must be located in the United States during the research. The website currently labels Career Development Award applications as closed. It also lists an NTSAD-ASGCT Translational Research Fellowship, described as one $50,000 award per year for up to two years, with applications listed as being accepted.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing lists Paula Cannon, PhD, as president; Matthew Porteus, MD, PhD, as vice president; and Federico Mingozzi, PhD, as treasurer. It also lists Jeffrey S. Chamberlain, PhD, and Hans-Peter Kiem, MD, PhD, as past presidents, and Claire Booth, MBBS, PhD; Kimberly Goodspeed, MD; Hildegard Buning, PhD; Miguel Sena-Esteves, PhD; and Maria-Grazia Roncarolo, MD, as part-year directors.
The American Society of Gene & Cell Therapy is led by David Barrett, Executive Director on every filing since 2020; 6 of 25 officers listed in 2024 are compensated.
Officers on the 2024 filing
David Barrett
Executive Director
On filings since 2020
40 hrs/week
$185K (2020) → $578K (2024)
Paula Cannon PhD
President
President Elect → President, 2024
On filings since 2023
5 hrs/week
No compensation reported
Hildegard Buning PhD
Director
On filings since 2021
3 hrs/week
No compensation reported
Maria-Grazia Roncarolo MD
Director
On filings since 2021
3 hrs/week
No compensation reported
Rayne H. Rouce MD
Director
On filings since 2021
3 hrs/week
No compensation reported
Aravind Asokan PhD
Director
On filings since 2023
3 hrs/week
No compensation reported
Daniel E. Bauer MD PhD
Director
On filings since 2023
3 hrs/week
No compensation reported
Jennifer Wellman Ms
Director
On filings since 2023
3 hrs/week
No compensation reported
Kah-Whye Peng PhD
Director
On filings since 2023
3 hrs/week
No compensation reported
Lindsey George MD
Director
On filings since 2023
3 hrs/week
No compensation reported
Punam Malik MD
Director
On filings since 2023
3 hrs/week
No compensation reported
Laura Michelle Gallagher
Employee
On filings since 2022
40 hrs/week
$131K (2022) → $215K (2024)
Margarita Lea Valdez
Employee
On filings since 2022
40 hrs/week
$148K (2022) → $242K (2024)
Jean Norton
Employee
New on the 2024 filing
40 hrs/week
$139K (2024)
Kellie Beumer
Employee
New on the 2024 filing
40 hrs/week
$154K (2024)
Ryan Hietpas
Employee
New on the 2024 filing
40 hrs/week
$170K (2024)
Federico Mingozzi PhD
Treasurer
Director → Treasurer, 2024
On filings since 2020
5 hrs/week
No compensation reported
Hans-Peter Kiem MD PhD
Past President
Vice President → President Elect, 2021
President Elect → Past President, 2023
On filings since 2020
5 hrs/week
No compensation reported
Terence R. Flotte MD
President Elect
Secretary → Vice President, 2023
Vice President → President Elect, 2024
On filings since 2020
5 hrs/week
No compensation reported
Jeffrey S. Chamberlain PhD
Past President
Vice President → President, 2023
President → Past President, 2024
On filings since 2021
5 hrs/week
No compensation reported
Isabelle Rivire PhD
Secretary
On filings since 2023
5 hrs/week
No compensation reported
Claire Booth Mbbs PhD
New on the 2024 filing
3 hrs/week
No compensation reported
Kimberly Goodspeed MD
New on the 2024 filing
3 hrs/week
No compensation reported
Matthew Porteus MD PhD
Vice President
New on the 2024 filing
5 hrs/week
No compensation reported
Miguel Sena-Esteves PhD
New on the 2024 filing
3 hrs/week
No compensation reported
Former officers (15)
- Former: Anastasia Khvorova PhD (2020–2023) — Director
- Former: Beverly Davidson PhD (2020–2023) — Past President
- Former: Marcela V. Maus MD PhD (2020–2023) — Director
- Former: Paloma H. Giangrande PhD (2020–2023) — Treasurer
- Former: Alex Wendland (2022–2023) — Employee
- Former: Grant Holley (2022–2023) — Employee
- Former: Betty Schiefelbein (2023) — Employee
- Former: Maritza McIntyre PhD (2020–2022) — Director
- Former: Matthew Wilson MD PhD (2020–2022) — Director
- Former: Philip Gregory Dphil (2020–2022) — Director
- Former: Stephen J. Russell MD PhD (2020–2022) — Past President
- Former: Courtney Michelle Bricker-Anthony (2022) — Employee
- Former: Jennifer E. Adair PhD (2020) — Director
- Former: Richard Morgan PhD (2020) — Director
- Former: Stephen L. Hart PhD (2020) — Director
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $578K, to David Barrett (Executive Director). 6 officers or directors reported compensation on that filing.
Frequently asked questions about The American Society of Gene & Cell Therapy
How much does The American Society of Gene & Cell Therapy give each year?
The American Society of Gene & Cell Therapy gave $1.0M across 10 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $1.5M across 15 grants.
What is The American Society of Gene & Cell Therapy's typical grant size?
The American Society of Gene & Cell Therapy's median grant in 2024 was $100,000, and its average grant was $104,000, across 10 grants on its 2024 IRS Form 990. Organizations receiving their first grant from The American Society of Gene & Cell Therapy that year got $100K on average.
Where does The American Society of Gene & Cell Therapy give grants?
The American Society of Gene & Cell Therapy's top state is Georgia, with 19% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were Pennsylvania (19%) and Washington (19%). The most frequent recipient cities were Seattle, WA (2 grants).
Does The American Society of Gene & Cell Therapy give general operating support?
Not in 2024: none of the 10 grants with a stated purpose on The American Society of Gene & Cell Therapy's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Career Development" (8 grants).
Who are The American Society of Gene & Cell Therapy's largest grantees?
The American Society of Gene & Cell Therapy's largest 2024 grantees include University of North Carolina at Chapel Hill ($200,000), Trustees of the University PA ($200,000) and Washington University ($100,000), according to its 2024 IRS Form 990. Together they received 48% of its itemized 2024 grant dollars.
How large is The American Society of Gene & Cell Therapy?
The American Society of Gene & Cell Therapy reported $27.0M in total assets on its 2024 IRS Form 990. Its revenue that year was $16.9M.
What does The American Society of Gene & Cell Therapy fund?
ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. See mission & focus areas ↑
How do I apply for a grant from The American Society of Gene & Cell Therapy?
Application requirements described for the Career Development Awards include selecting a research topic and providing a mentor letter of support. Eligibility and process details are in the grantmaking section of this profile. See how to apply ↑
What is The American Society of Gene & Cell Therapy's EIN?
The American Society of Gene & Cell Therapy's EIN (Employer Identification Number) is 91-1766321. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 12, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS October 21, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 9, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 4, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 17, 2025)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work The American Society of Gene & Cell Therapy funds
Medical Research Open opportunities, soonest deadline first.
- 2026 USS Translational Research Grant Up to $100,000 per year · Due October 24, 2026
- Dr. Richard A. Falls Virginia Lions Eye Institute Research Grant Up to $40,000 (yearly total budget) · Due October 25, 2026
- NSF Graduate Research Fellowship Program (GRFP) $32,000 annually plus $12,000 cost of education allowance · Due October 27, 2026
Explore Open Grants
Browse active grant opportunities in The American Society of Gene & Cell Therapy's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Yale University
New Haven, CT
Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.
Assets
$58.9B
Grants
364
Total Given
$168.2M
Johns Hopkins University
Baltimore, MD
Johns Hopkins University funds a broad range of education, research, health, and community-related work, with 2025 grants ranging from $5,500 to nearly $95 million and a median of $100,000; many of the largest awards were sub-awards. Its grants went to organizations across the U.S., with the largest shares in California and Maryland, and the profile does not state whether it accepts unsolicited requests.
Assets
$25.3B
Grants
813
Total Given
$594.1M
American Heart Association Inc
Dallas, TX
The American Heart Association funds basic, clinical, behavioral, translational and population research on cardiovascular, cerebrovascular and brain health, along with research training and education programs. In 2025 it awarded 833 grants totaling about $198 million; amounts ranged from $5,000 to nearly $9.93 million, with a median of $20,000. Research awards are for eligible U.S.-based nonprofit institutions, and the profile describes a formal proposal process but does not state whether unsolicited requests are accepted.
Assets
$2.0B
Grants
833
Total Given
$198.2M
Emory University
Atlanta, GA
Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.
Assets
$24.9B
Grants
362
Total Given
$183.7M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
American Cancer Society Inc
Atlanta, GA
The American Cancer Society funds cancer research, patient support, and advocacy, including grants to researchers, institutions, and related organizations. Its 2025 grants ranged from $5,648 to $9.6 million, with a median of $15,000; research funding supports institutions across the United States. It accepts applications for specific research programs through ProposalCentral, but the profile does not state whether it accepts unsolicited requests generally.
Assets
$1.7B
Grants
509
Total Given
$23.1M
More similar funders
More Funders in Wisconsin
Cite this profile
Grantable. (2026). The American Society of Gene & Cell Therapy funder profile. GrantGraph. Retrieved October 24, 2026, from https://grantable.co/funders/the-american-society-of-gene-and-cell-therapy-morg_ffcb4cdfbc7b4fb98b8db24d3706249b
BibTeX
@misc{grantable_911766321_2026,
author = {{Grantable}},
title = {{The American Society of Gene \& Cell Therapy funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/the-american-society-of-gene-and-cell-therapy-morg_ffcb4cdfbc7b4fb98b8db24d3706249b},
note = {Accessed 2026-10-24. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from The American Society of Gene & Cell Therapy's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
The American Society of Gene & Cell Therapy down — hundreds of funders to go?